Literature DB >> 23640193

Clinical pharmacology in everyday clinical care.

Petra A Thürmann1.   

Abstract

Since direct patient care is only one of the many fields of clinical pharmacologists world wide, the contribution of the discipline to the provision of healthcare is frequently underestimated. Besides therapeutic monitoring and pharmacogenetic services, particularly drug information services run by clinical pharmacology departments have been established in many countries. Despite the fact that electronic prescribing support may prevent physicians from major medication errors due to drug-drug interactions and inadequate dosages, a substantial number of questions addressed to drug information services include clinical expertise and judgement. Furthermore, a high number of requests deal with adverse drug interactions and involve requests for alternative drugs in the individual clinical context. Using information technology, an international web-based clinical pharmacology service using existing knowledge databases seems to be a promising option to demonstrate the excellence of the discipline.

Entities:  

Mesh:

Year:  2013        PMID: 23640193     DOI: 10.1007/s00228-013-1490-z

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  27 in total

1.  Regional drug information service.

Authors:  U I Schwarz; S Stoelben; U Ebert; M Siepmann; J Krappweis; W Kirch
Journal:  Int J Clin Pharmacol Ther       Date:  1999-06       Impact factor: 1.366

2.  Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group.

Authors:  L D Jacobs; R W Beck; J H Simon; R P Kinkel; C M Brownscheidle; T J Murray; N A Simonian; P J Slasor; A W Sandrock
Journal:  N Engl J Med       Date:  2000-09-28       Impact factor: 91.245

3.  Provision of medicines information: the example of the British National Formulary.

Authors:  Martin Kendall; Duncan Enright
Journal:  Br J Clin Pharmacol       Date:  2012-06       Impact factor: 4.335

4.  Reassessment of the benefit/risk-ratio of selective COX-2-inhibitors.

Authors:  Ulrich Klotz
Journal:  Swiss Med Wkly       Date:  2005-03-19       Impact factor: 2.193

5.  SFINX-a drug-drug interaction database designed for clinical decision support systems.

Authors:  Ylva Böttiger; Kari Laine; Marine L Andersson; Tuomas Korhonen; Björn Molin; Marie-Louise Ovesjö; Tuire Tirkkonen; Anders Rane; Lars L Gustafsson; Birgit Eiermann
Journal:  Eur J Clin Pharmacol       Date:  2009-02-11       Impact factor: 2.953

6.  Clinical pharmacology in Europe: an indispensible part of the health service. WHO Working Group on Clinical Pharmacology in Europe.

Authors: 
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

7.  Public understanding of drug therapy.

Authors:  Andrew Herxheimer
Journal:  Br J Clin Pharmacol       Date:  2012-06       Impact factor: 4.335

8.  Clinical pharmacology and primary health care in Europe--a gap to bridge. The WHO Working Group on Clinical Pharmacology in Europe.

Authors:  G Dukes; P K Lunde; A Melander; M Orme; F Sjöqvist; G Tognoni; H Wesseling
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

9.  Comprehensive clinical drug information service: first year's experience.

Authors:  D M Davies; C H Ashton; J G Rao; M D Rawlins; P A Routledge; R L Savage; J W Thompson; M A Zar
Journal:  Br Med J       Date:  1977-01-08

10.  Which factors predict the time spent answering queries to a drug information centre?

Authors:  Linda A Reppe; Olav Spigset; Jan Schjøtt
Journal:  Pharm World Sci       Date:  2010-10-05
View more
  3 in total

Review 1.  Norwegian drug information centres strongly promote person-centred and personalised medicine: a brief report on the achievements and strategy.

Authors:  Jan Schjøtt
Journal:  EPMA J       Date:  2019-04-30       Impact factor: 6.543

2.  Therapeutic enquiries about biological agents as a tool to identify safety aspects and patterns of use.

Authors:  D Salat; R Llop; C Aguilera; I Danés; M Bosch; C Asensio; F Castañeda; E Esterlich; A Vallano
Journal:  Eur J Hosp Pharm       Date:  2015-10-28

3.  Use of References in Responses from Scandinavian Drug Information Centres.

Authors:  Jan Schjøtt; Ylva Böttiger; Per Damkier; Linda Amundstuen Reppe; Jens Peter Kampmann; Hanne Rolighed Christensen; Olav Spigset
Journal:  Medicines (Basel)       Date:  2018-07-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.